JPS4848621A - - Google Patents

Info

Publication number
JPS4848621A
JPS4848621A JP8357671A JP8357671A JPS4848621A JP S4848621 A JPS4848621 A JP S4848621A JP 8357671 A JP8357671 A JP 8357671A JP 8357671 A JP8357671 A JP 8357671A JP S4848621 A JPS4848621 A JP S4848621A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8357671A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP8357671A priority Critical patent/JPS4848621A/ja
Publication of JPS4848621A publication Critical patent/JPS4848621A/ja
Pending legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP8357671A 1971-10-20 1971-10-20 Pending JPS4848621A (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8357671A JPS4848621A (de) 1971-10-20 1971-10-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8357671A JPS4848621A (de) 1971-10-20 1971-10-20

Publications (1)

Publication Number Publication Date
JPS4848621A true JPS4848621A (de) 1973-07-10

Family

ID=13806316

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8357671A Pending JPS4848621A (de) 1971-10-20 1971-10-20

Country Status (1)

Country Link
JP (1) JPS4848621A (de)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897549A (en) * 1973-03-30 1975-07-29 Rit Rech Ind Therapeut Herpes simplex type 2 virus vaccine and method of production and use
EP0230265A2 (de) * 1986-01-23 1987-07-29 BEHRINGWERKE Aktiengesellschaft Stabilisiertes Virus-Antigen, Verfahren zu seiner Herstellung und seine Verwendung
US5360736A (en) * 1992-06-04 1994-11-01 Merck & Co., Inc. Process for attenuated varicella zoster virus vaccine production
WO1999055348A3 (en) * 1998-04-24 1999-12-16 Cantab Pharmaceuticals Res Ltd Stabilised virus preparation

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897549A (en) * 1973-03-30 1975-07-29 Rit Rech Ind Therapeut Herpes simplex type 2 virus vaccine and method of production and use
EP0230265A2 (de) * 1986-01-23 1987-07-29 BEHRINGWERKE Aktiengesellschaft Stabilisiertes Virus-Antigen, Verfahren zu seiner Herstellung und seine Verwendung
US5360736A (en) * 1992-06-04 1994-11-01 Merck & Co., Inc. Process for attenuated varicella zoster virus vaccine production
WO1999055348A3 (en) * 1998-04-24 1999-12-16 Cantab Pharmaceuticals Res Ltd Stabilised virus preparation

Similar Documents

Publication Publication Date Title
ATA136472A (de)
AR196074A1 (de)
JPS4848621A (de)
AU2658571A (de)
AU2691671A (de)
AU2684071A (de)
AU3005371A (de)
AU2564071A (de)
AU2894671A (de)
AU2742671A (de)
AU2485671A (de)
AU2941471A (de)
AU2952271A (de)
AU2907471A (de)
AU2880771A (de)
AU2963771A (de)
AU3038671A (de)
AU2755871A (de)
AU2940971A (de)
AU2938071A (de)
AU2486471A (de)
AU2930871A (de)
AU2927871A (de)
AU2503871A (de)
AU2577671A (de)